Infection of the macrophage cell line NR8383 with Mycobacterium tuberculosis (H37Ra) leads to an increase in oligodeoxynucleotide accumulation.
暂无分享,去创建一个
[1] I. Tebbett,et al. Cocaine Suppresses Fetal Immune System , 1998, Pediatric Research.
[2] J. Ernst,et al. Macrophage Receptors for Mycobacterium tuberculosis , 1998, Infection and Immunity.
[3] G. H. Zhang,et al. Regulation of cytosolic free Ca2+ in cultured rat alveolar macrophages (NR8383) , 1997, Journal of leukocyte biology.
[4] W. Martin,et al. Surfactant protein A (SP-A) mediates attachment of Mycobacterium tuberculosis to murine alveolar macrophages. , 1997, American journal of respiratory cell and molecular biology.
[5] K. Edwards,et al. SP-A enhances uptake of bacillus Calmette-Guérin by macrophages through a specific SP-A receptor. , 1997, The American journal of physiology.
[6] J. Pieters,et al. Isolation and characterization of the mycobacterial phagosome: segregation from the endosomal/lysosomal pathway , 1997, Molecular microbiology.
[7] J. Loike,et al. Mac-1 (CD11b/CD18) is an oligodeoxynucleotide-binding protein , 1997, Nature Medicine.
[8] G. Chaudhuri. Scavenger receptor-mediated delivery of antisense mini-exon phosphorothioate oligonucleotide to Leishmania-infected macrophages. Selective and efficient elimination of the parasite. , 1997, Biochemical pharmacology.
[9] J. Keane,et al. Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis , 1997, Infection and immunity.
[10] S. Iyer,et al. Differences in mannose receptor-mediated uptake of lipoarabinomannan from virulent and attenuated strains of Mycobacterium tuberculosis by human macrophages. , 1996, Journal of immunology.
[11] M. Horwitz,et al. The Mycobacterium tuberculosis phagosome interacts with early endosomes and is accessible to exogenously administered transferrin , 1996, The Journal of experimental medicine.
[12] D. Russell,et al. Mycobacterium avium- and Mycobacterium tuberculosis-containing vacuoles are dynamic, fusion-competent vesicles that are accessible to glycosphingolipids from the host cell plasmalemma. , 1996, Journal of immunology.
[13] M. Fenton,et al. Immunopathology of tuberculosis: roles of macrophages and monocytes , 1996, Infection and immunity.
[14] V. Metelev,et al. Antimycobacterial activities of antisense oligodeoxynucleotide phosphorothioates in drug-resistant strains. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[15] Y. Oh,et al. Formulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infection , 1995, Antimicrobial agents and chemotherapy.
[16] M. Brown,et al. Lipoarabinomannans derived from different strains of Mycobacterium tuberculosis differentially stimulate the activation of NF-kappa B and KBF1 in murine macrophages , 1995, Infection and immunity.
[17] J. Toulmé,et al. Antisense phosphorothioate oligonucleotides: selective killing of the intracellular parasite Leishmania amazonensis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[18] N. Reiner,et al. Altered cell signaling and mononuclear phagocyte deactivation during intracellular infection. , 1994, Immunology today.
[19] P. Das,et al. Neoglycoprotein conjugated liposomes as macrophage specific drug carrier in the therapy of leishmaniasis. , 1994, Biochemical and biophysical research communications.
[20] H. P. Gupta,et al. Tuftsin-bearing liposomes as rifampin vehicles in treatment of tuberculosis in mice , 1994, Antimicrobial Agents and Chemotherapy.
[21] P. Schlesinger,et al. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. , 1994, Science.
[22] C. Smith,et al. Complement and tumor necrosis factor‐α contribute to Mac‐1 (CD11b/CD18) up‐regulation and systemic neutrophil activation during endotoxemia in vivo , 1994, Journal of leukocyte biology.
[23] L. Schlesinger. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. , 1993, Journal of immunology.
[24] A. Periasamy,et al. Mechanism of cellular uptake of modified oligodeoxynucleotides containing methylphosphonate linkages. , 1991, Nucleic acids research.
[25] E. Uhlmann,et al. Antisense oligonucleotides: a new therapeutic principle , 1990 .
[26] L. Neckers,et al. Characterization of oligonucleotide transport into living cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[27] K. Jayaraman,et al. Selective inhibition of Escherichia coli protein synthesis and growth by nonionic oligonucleotides complementary to the 3' end of 16S rRNA. , 1981, Proceedings of the National Academy of Sciences of the United States of America.